<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00366119</url>
  </required_header>
  <id_info>
    <org_study_id>RMN-P01</org_study_id>
    <nct_id>NCT00366119</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension</brief_title>
  <official_title>Phase 4 Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Ramiprin Tab. in Essential Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pacific Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pacific Pharmaceuticals</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess which drug is more effective of Ramiprin®(ramipril)
      and Tritace®(ramipril) in the Treatment of Essential Hypertension
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2006</start_date>
  <completion_date>June 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of DBP(diastolic blood pressure)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of SBP(systolic blood pressure)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with Dcrease of BP(blood pressure)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with a Normalization of BP(blood pressure)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Artery stiffness(chang of pulse wave velocity)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular diastolic function</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of BNP</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of CRP</measure>
  </secondary_outcome>
  <enrollment>86</enrollment>
  <condition>Essential Hypertension</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ramipril</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mild and moderate essential hypertension (90mmHg≤DBP≤110mmHg)

        Exclusion Criteria:

          -  180mmHg≤SBP

          -  If differences greater than 20mmHg for SBP and 10mmHg for DBP between both arms are
             present on 3 consecutive readings

          -  If differences greater than 20mmHg for SBP and 10mmHg for DBP are present on 3
             consecutive readings

          -  impaired hepatic function

          -  imapaired renal function

          -  angioedema

          -  aortic valvular stenosis or obstrcutive ejection disorder

          -  primary hyperaldosteronism

          -  renal transplantation, bilateral renal artery stenosis or unilateral stenosis in a
             single kidney, hemodialysis

          -  severe respiratory disease

          -  congestive heart failure( New York Association functional class Ⅲ or Ⅳ)

          -  malignant hypertension

          -  labile angina pectoris or myocardial infarction in the last 3 months before study
             entry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>HyoSoo Kim, Ph.D in MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <state>28 Yeongeon-dong, Jongno-gu</state>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2006</study_first_submitted>
  <study_first_submitted_qc>August 17, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2006</study_first_posted>
  <last_update_submitted>March 8, 2007</last_update_submitted>
  <last_update_submitted_qc>March 8, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 9, 2007</last_update_posted>
  <keyword>hypertension</keyword>
  <keyword>ramipril</keyword>
  <keyword>blood pressure</keyword>
  <keyword>artery stiffness</keyword>
  <keyword>BNP</keyword>
  <keyword>CRP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ramipril</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

